DBV TECHNOLOGIES (EPA:DBV)

BRIEF

published on 03/24/2025 at 07:35, 1 year 5 months ago

DBV Technologies Anticipates Regulatory Progress with the FDA

FDA Agreement DBV Technologies Viaskin Peanut Treasury 2024 SPEED Study
PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 5 months ago

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
DBV Technologies secures FDA agreement for Viaskin Peanut Patch BLA submission in 4-7-year-olds, accelerating launch timeline by approximately one year. Unaudited 2024 financial results reported

FDA Agreement DBV Technologies Unaudited Financial Results Viaskin Peanut Patch BLA Submission
BRIEF

published on 02/25/2025 at 22:06, 1 year 6 months ago

DBV Technologies at AAAAI/WAO Congress to Present Advances in Peanut Allergy

Clinical Study DBV Technologies Peanut Allergy AAAAI/WAO Congress VIASKIN® Patch
PRESS RELEASE

published on 02/25/2025 at 22:01, 1 year 6 months ago

DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
DBV Technologies to participate in AAAAI/WAO Joint Congress to present long-term efficacy results of epicutaneous immunotherapy with VIASKIN peanut patch in peanut-allergic children aged 4-11 years, showcasing treatment benefits and high compliance rates

DBV Technologies Epicutaneous Immunotherapy Viaskin Peanut Patch AAAAI/WAO Joint Congress PEPITES Study
BRIEF

published on 01/13/2025 at 22:10, 1 year 7 months ago

DBV Technologies Half-Yearly Liquidity Statement

Liquidity Contract ODDO BHF Stock Market Transactions DBV Technologies VIASKIN®
PRESS RELEASE

published on 01/13/2025 at 22:05, 1 year 7 months ago

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
DBV Technologies issues Half-Year Report on liquidity contract with ODDO BHF, revealing assets in the account and transaction details

Liquidity Contract Half-year Report Biopharmaceutical Company ODDO BHF DBV Technologies
BRIEF

published on 12/02/2024 at 22:35, 1 year 9 months ago

DBV Technologies: Voting rights and shares as of November 30, 2024

Share Capital Voting Rights Actions DBV Technologies NYSE Euronext Paris
PRESS RELEASE

published on 12/02/2024 at 22:30, 1 year 9 months ago

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024
Company provides update on total voting rights and shares as of November 30, 2024 in compliance with AMF regulations

Shares Total Voting Rights AMF Regulations NYSE Euronext Paris November 30 2024
BRIEF

published on 11/20/2024 at 15:33, 1 year 9 months ago

Braidwell LP Crosses Thresholds at DBV Technologies

Actions Investment Crossing Thresholds DBV Technologies Braidwell LP
BRIEF

published on 11/06/2024 at 22:35, 1 year 10 months ago

DBV Technologies Facing Financial Uncertainties in Q3 2024

Financial Results Cash Flow Net Loss Q3 2024 DBV Technologies

Published on 09/12/2026 at 02:35, 1 day 18 hours ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 22 hours ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 day 23 hours ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 2 days ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 4 hours ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

Published on 09/12/2026 at 17:50, 1 day 3 hours ago

New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 13 hours ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 23 hours ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 23 hours ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 2 days 1 hour ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031

View all EQS

Published on 09/11/2026 at 07:00, 2 days 14 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 2 days 14 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 1 hour ago

Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 07:00, 3 days 14 hours ago

2026 H1 results and new identity
Published on 09/09/2026 at 18:45, 4 days 2 hours ago

Successful launch of a €500 million bond issue

View all LES ECHOS COMFI WIRE

News